144 results on '"Springer, Simeon"'
Search Results
2. Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma
3. Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology
4. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
5. Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs)
6. Correction to: Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology
7. Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations
8. Data from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
9. Supplementary Figure 4 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
10. Supplementary Figure 1 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
11. Supplementary Figure 5 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
12. Supplementary Table 2 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
13. Supplementary Table 1 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
14. Supplementary Figure 3 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
15. Supplementary Figure 2 from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
16. Supplementary Methods, Figure Legends from Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
17. Data from TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
18. Supplementary Table 1 from TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
19. Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder
20. High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder
21. Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder
22. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
23. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma
24. Evaluation of Liquid From the Papanicolaou Test and Other Liquid Biopsies for the Detection of Endometrial and Ovarian Cancers
25. A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts
26. Engineering targeted chromosomal amplifications in human breast epithelial cells
27. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
28. Global genome analysis reveals a vast and dynamic anellovirus landscape within the human virome
29. Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations
30. Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology
31. A multimodality test to guide the management of patients with a pancreatic cyst
32. Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations
33. Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
34. MP65-13 UROSEEK: A NOVEL NON-INVASIVE MOLECULAR METHOD FOR EARLY DETECTION OF BLADDER CANCER
35. MP65-14 UROSEEK: A NOVEL NON-INVASIVE MOLECULAR ASSAY FOR SURVEILLANCE OF BLADDER CANCER
36. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
37. Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
38. Author response: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
39. Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidy
40. Non-invasive detection of upper tract urothelial carcinomas through the analysis of driver gene mutations and aneuploidy in urine
41. 1124 A MULTI-MODALITY TEST TO GUIDE THE MANAGEMENT OF PATIENTS WITH PANCREATIC CYSTS
42. Diagnostic potential of tumor DNA from ovarian cyst fluid
43. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
44. A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts
45. Author response: Diagnostic potential of tumor DNA from ovarian cyst fluid
46. The potential of circulating tumor DNA (ctDNA) to reshape the design of clinical trials testing adjuvant therapy in patients with early stage cancers.
47. 597 Molecular Markers Help Define Cyst Type in the Pancreas: An International, Multicenter Study of Over 300 Cysts
48. A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
49. Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
50. Abstract 4004: Molecular characterization of circulating glioblastoma cells identifies a mesenchymal-like tumor cell subpopulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.